BioMed Research International
Volume 2017 (2017), Article ID 5782619, 1 page
https://doi.org/10.1155/2017/5782619

Corrigendum

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”

Ling-Gang Cheng,¹ Wen He,¹ Hong-Xia Zhang,¹ Qian Song,¹ Bin Ning,¹ Hui-Zhan Li,¹ Yan He,¹ and Song Lin²

¹Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China
²Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China

Correspondence should be addressed to Hong-Xia Zhang; zhanghxttyy@sina.com

Received 20 October 2016; Accepted 8 November 2016; Published 18 July 2017

Copyright © 2017 Ling-Gang Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma” [1], there were errors in the Materials and Methods and Results sections, as mentioned in a Letter to the Editor by Mahalangikar et al. [2], which should be corrected as follows.

In Section  2.7.3 (Expression of VEGF), “41% to 75% was (+)” should be corrected to “41% to 75% was (+ +).”

The age ranges were incorrectly reported in Section  3.1 (The Basic Condition of the Patients) as “20 to 69 years with a mean age of 47.9 ± 11.4” and should be corrected to “18 to 69 years with a mean age of 45 ± 12.8 years.”

References

L.-G. Cheng, W. He, H.-X. Zhang et al., “Intraoperative contrast enhanced ultrasound evaluates the grade of glioma,” BioMed Research International, vol. 2016, Article ID 2643862, 9 pages, 2016.

R. Mahalangikar, S. Sinha, and R. Sharma, “Comment on ‘intraoperative contrast enhanced ultrasound evaluates the grade of glioma’,” BioMed Research International, vol. 2017, Article ID 3570895, 2 pages, 2017.